Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota

With improved standards of living, the incidence of multiple metabolic disorders has increased year by year, especially major risk factors for cardiovascular disease such as hyperglycemia and hyperlipidemia, continues to increase. Emerging epidemiological data and clinical trials have shown the addi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Qi-You, Tian, Jia-Xing, Li, Min, Lian, Feng-Mei, Zhao, Lin-Hua, Wei, Xiu-Xiu, Han, Lin, Zheng, Yu-Jiao, Gao, Ze-Zheng, Yang, Hao-Yu, Fang, Xin-Yi, Tong, Xiao-lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644821/
https://www.ncbi.nlm.nih.gov/pubmed/33194785
http://dx.doi.org/10.3389/fcimb.2020.530160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644821/
https://www.ncbi.nlm.nih.gov/pubmed/33194785
http://dx.doi.org/10.3389/fcimb.2020.530160

Ejemplares similares